Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  varenicline
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-8 of 8 for your search:
Start Over
Smoking Cessation Program in the Preadmission Clinic
Phase: Phase IV
Type: Behavioral study, Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 07-0585-AE, Protocol# in Pfizer: GA30517W, NCT00937508
Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity
Phase: Phase IV
Type: Behavioral study, Prevention
Status: Active
Age: 16 to 45
Sponsor: Other
Protocol IDs: P50DA016511, NCT00664755
Reward Sensitivity and Pharmacotherapy for Smoking Cessation
Phase: Phase IV
Type: Behavioral study, Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2014-0207, NCI-2014-01485, NCT02162849
Varenicline and Combined Nicotine Replacement Therapy (NRT) for Smoking Cessation
Phase: Phase IV
Type: Behavioral study, Prevention
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2014-0213, NCI-2015-00610, NCT02271919
Behavioral Activation and Varenicline for Smoking Cessation in Depressed Smokers
Phase: Phase IV
Type: Behavioral study
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: STU00100303, 1R01CA184211-01A1, NCT02378714
Extended Varenicline Treatment for Smoking Among Cancer Patients
Phase: Phase III
Type: Behavioral study
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: R01CA165001, NCT01756885
Smoking Cessation Strategies in Community Cancer Programs for Lung and Head and Neck Cancer Patients
Phase: Phase II
Type: Behavioral study
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: KCTN-1301, NCT02048917
Varenicline and Motivational Advice for Smokers With Substance Use Disorders
Phase: No phase specified
Type: Behavioral study
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: 1RO1DA02465201, NIH Appl. ID: 7439661, NIH Award: RDA024652A, NCT00756275
Start Over